Duke researchers develop treatment that triples survival time of brain cancer patients
By Nathan Luzum | May 5, 2017Glioblastoma is among the most obstinate forms of brain cancer, with patients having a median survival time of just under 15 months. Thanks to a new treatment tested by Duke scientists, however, survival chances for glioblastoma patients may soon improve.